StockpollyBeta
Get App
Delisting riskPopularity #3,972
VVOS · NASDAQ · Medical - Devices

Vivos Therapeutics (VVOS)

Oral-appliance therapy, sleep testing and clinical-practice support for obstructive sleep apnea.

$0.1474
vs last close−0.01 (−5.87%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue333444347455
Cost of revenue211122223132
Gross profit222322224333
566555579998
566455578997
Selling & marketing111000000000
General & administrative555444568997
Other expenses000000000001
Operating income−4−4−4−2−3−3−4−5−5−6−7−5
20000000−1−1−1−1
Interest expense030000000001
Other non-operating income0−30000001110
Income before tax−2−4−4−2−3−3−4−5−5−7−8−6
Net income from continuing operations−2−4−4−2−3−3−4−5−5−7−8−6
Net income−2−4−4−2−3−3−4−5−5−7−8−5
EPS, basic−$1.75−$2.32−$1.63−$0.60−$0.40−$0.48−$0.45−$0.55−$0.49−$0.74−$0.52−$0.31
EPS, diluted−$1.75−$2.32−$1.63−$0.60−$0.40−$0.48−$0.45−$0.55−$0.49−$0.74−$0.52−$0.31
Weighted average shares, basic122376991191518
Weighted average shares, diluted122376991191518
EBITDA−3−1−4−2−2−3−4−5−5−7−7−4
Depreciation & amortization000000000000
EBIT−4−1−4−2−3−3−4−5−5−7−8−4